Role of Senescent Astrocytes in Health and Disease

For many decades after their discovery, astrocytes, the abundant glial cells of the brain, were believed to work as a glue, supporting the structure and metabolic functions of neurons. A revolution that started over 30 years ago revealed many additional functions of these cells, including neurogenesis, gliosecretion, glutamate homeostasis, assembly and function of synapses, neuronal metabolism with energy production, and others. These properties have been confirmed, limited however, to proliferating astrocytes. During their aging or following severe brain stress lesions, proliferating astrocytes are converted into their no-longer-proliferating, senescent forms, similar in their morphology but profoundly modified in their functions. The changed specificity of senescent astrocytes is largely due to their altered gene expression. The ensuing effects include downregulation of many properties typical of proliferating astrocytes, and upregulation of many others, concerned with neuroinflammation, release of pro-inflammatory cytokines, dysfunction of synapses, etc., specific to their senescence program. The ensuing decrease in neuronal support and protection by astrocytes induces the development, in vulnerable brain regions, of neuronal toxicity together with cognitive decline. Similar changes, ultimately reinforced by astrocyte aging, are also induced by traumatic events and molecules involved in dynamic processes. Senescent astrocytes play critical roles in the development of many severe brain diseases. The first demonstration, obtained for Alzheimer’s disease less than 10 years ago, contributed to the elimination of the previously predominant neuro-centric amyloid hypothesis. The initial astrocyte effects, operating a considerable time before the appearance of known Alzheimer’s symptoms evolve with the severity of the disease up to their proliferation during the final outcome. Involvement of astrocytes in other neurodegenerative diseases and cancer is now intensely investigated.

[1]  M. Nonnemacher,et al.  Roles of neuropathology-associated reactive astrocytes: a systematic review , 2023, Acta Neuropathologica Communications.

[2]  L. Bodea,et al.  Editorial: The neuron-glia crosstalk and beyond , 2023, Frontiers in Cellular Neuroscience.

[3]  R. Vidal,et al.  Are cytoskeleton changes observed in astrocytes functionally linked to aging? , 2023, Brain Research Bulletin.

[4]  S. Sarkar,et al.  The autophagy-NAD axis in longevity and disease. , 2023, Trends in cell biology.

[5]  Madeline G. Andrews,et al.  Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations , 2023, The Journal of clinical investigation.

[6]  C. Suemoto,et al.  Age-Associated Upregulation of Glutamate Transporters and Glutamine Synthetase in Senescent Astrocytes In Vitro and in the Mouse and Human Hippocampus , 2023, ASN neuro.

[7]  Hui Huang,et al.  MicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases , 2023, Frontiers in Molecular Neuroscience.

[8]  J. Bengzon,et al.  Transcription Factor–Forced Astrocytic Differentiation Impairs Human Glioblastoma Growth In Vitro and In Vivo , 2022, Molecular cancer therapeutics.

[9]  Jie Zhang,et al.  Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases , 2022, CNS neuroscience & therapeutics.

[10]  R. Rebollar-Vega,et al.  The Transcriptomic Landscape of Pediatric Astrocytoma , 2022, International journal of molecular sciences.

[11]  D. Capper,et al.  The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology , 2022, Journal of Neuro-Oncology.

[12]  L. Dumas,et al.  Astrocyte development in the cerebral cortex: Complexity of their origin, genesis, and maturation , 2022, Frontiers in Neuroscience.

[13]  E. Ruppin,et al.  Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity. , 2022, Brain : a journal of neurology.

[14]  C. Torres,et al.  Involvement of astrocyte senescence in Alzheimer's disease , 2022, Current Opinion in Neurobiology.

[15]  Gang Chen,et al.  Novel Therapeutic Strategies for Ischemic Stroke: Recent Insights into Autophagy , 2022, Oxidative medicine and cellular longevity.

[16]  Kyong-Tai Kim,et al.  Region-Specific Characteristics of Astrocytes and Microglia: A Possible Involvement in Aging and Diseases , 2022, Cells.

[17]  M. Stevanović,et al.  Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies , 2022, International journal of molecular sciences.

[18]  E. Pyza,et al.  Glia-Neurons Cross-Talk Regulated Through Autophagy , 2022, Frontiers in Physiology.

[19]  D. Kaufer,et al.  Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation , 2022, bioRxiv.

[20]  R. D'Hooge,et al.  Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease , 2022, bioRxiv.

[21]  A. Verkhratsky,et al.  The great astroglial metabolic revolution: Mitochondria fuel astrocyte homeostatic support and neuroprotection. , 2022, Cell calcium.

[22]  Michael R. Barnes,et al.  Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape , 2022, bioRxiv.

[23]  J. Cummings,et al.  Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease , 2022, The European journal of neuroscience.

[24]  OUP accepted manuscript , 2022, Brain.

[25]  A. Nordberg,et al.  Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease , 2021, Journal of neurochemistry.

[26]  Amaia M. Arranz,et al.  Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques , 2021, Molecular neurodegeneration.

[27]  Tyler K. Ulland,et al.  Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease , 2021, Frontiers in Cellular Neuroscience.

[28]  T. Kozlova,et al.  Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer’s Disease , 2021, Biomedicines.

[29]  W. Gordon,et al.  Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease , 2021, Acta Neuropathologica Communications.

[30]  J. Meldolesi Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases , 2021, Molecular Biomedicine.

[31]  J. Meldolesi,et al.  Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success , 2021, Biomedicines.

[32]  A. D. R. Garcia New Tricks for an Old (Hedge)Hog: Sonic Hedgehog Regulation of Astrocyte Function , 2021, Cells.

[33]  B. Ghetti,et al.  Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain , 2021, Molecular Psychiatry.

[34]  Jian Li,et al.  Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain , 2021, Autophagy.

[35]  Ling Lin,et al.  Identification of potential candidate proteins for reprogramming spinal cord-derived astrocytes into neurons: a proteomic analysis , 2021, Neural regeneration research.

[36]  Kira E. Poskanzer,et al.  Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.

[37]  Brandon J. Henderson,et al.  Astrocyte-Derived Thrombospondin Induces Cortical Synaptogenesis in a Sex-Specific Manner , 2021, eNeuro.

[38]  OUP accepted manuscript , 2021, Brain.

[39]  Jin He,et al.  Autophagy protects against cerebral ischemic reperfusion injury by inhibiting neuroinflammation. , 2021, American journal of translational research.

[40]  M. Narita,et al.  Autophagy and senescence, converging roles in pathophysiology as seen through mouse models. , 2021, Advances in cancer research.

[41]  Hunter L Porter,et al.  Inducible cell-specific mouse models for paired epigenetic and transcriptomic studies of microglia and astroglia , 2020, Communications Biology.

[42]  J. Meldolesi Astrocytes: News about Brain Health and Diseases , 2020, Biomedicines.

[43]  B. Strooper,et al.  Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer’s Disease , 2020, Neuron.

[44]  N. Brandon,et al.  Axl receptor tyrosine kinase is a regulator of apolipoprotein E , 2020, Molecular Brain.

[45]  Jamie L. Marshall,et al.  Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.

[46]  M. Hasegawa,et al.  Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases , 2020, Brain pathology.

[47]  G. Kovacs Astroglia and Tau: New Perspectives , 2020, Frontiers in Aging Neuroscience.

[48]  N. Neff,et al.  Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease , 2020, Nature Neuroscience.

[49]  Jie Pan,et al.  Transcriptomic profiling of microglia and astrocytes throughout aging , 2020, Journal of Neuroinflammation.

[50]  Cédric G. Geoffroy,et al.  The Influence of Neuron-Extrinsic Factors and Aging on Injury Progression and Axonal Repair in the Central Nervous System , 2020, Frontiers in Cell and Developmental Biology.

[51]  Z. Shah,et al.  The role of cofilin in age-related neuroinflammation , 2020, Neural regeneration research.

[52]  T. Oron,et al.  Astrocyte senescence promotes glutamate toxicity in cortical neurons , 2020, PloS one.

[53]  C. Stary,et al.  Adult neurogenesis from reprogrammed astrocytes , 2019, Neural regeneration research.

[54]  M. Papa,et al.  Regional brain susceptibility to neurodegeneration: what is the role of glial cells? , 2019, Neural regeneration research.

[55]  M. Guillermier,et al.  Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease , 2019, Neurobiology of Aging.

[56]  Jun-Ling Wang,et al.  Astrocytes autophagy in aging and neurodegenerative disorders. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  L. V. Van Eldik,et al.  Effects of advanced age upon astrocyte-specific responses to acute traumatic brain injury in mice , 2019, Journal of Neuroinflammation.

[58]  Janet E. Holley,et al.  Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14ARF, and TAU3 transcript expression and contribute to cognitive decline , 2019, GeroScience.

[59]  E. Musiek,et al.  Circadian regulation of astrocyte function: implications for Alzheimer’s disease , 2019, Cellular and Molecular Life Sciences.

[60]  S. Cuzzocrea,et al.  Astrocytes: Role and Functions in Brain Pathologies , 2019, Front. Pharmacol..

[61]  T. Schmitz,et al.  Ischemic stroke in neonatal and adult astrocytes , 2019, Mechanisms of Ageing and Development.

[62]  S. Gaetani,et al.  Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes , 2019, Neurotherapeutics.

[63]  T. Cassano,et al.  Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice , 2019, Front. Pharmacol..

[64]  K. Okamoto,et al.  Astrocytic tau pathologies in aged human brain , 2019, Neuropathology : official journal of the Japanese Society of Neuropathology.

[65]  Jialin C. Zheng,et al.  Reactive Astrocytes in Neurodegenerative Diseases , 2019, Aging and disease.

[66]  Amaia M. Arranz,et al.  The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications , 2019, The Lancet Neurology.

[67]  F. Gomes,et al.  Astrocyte Heterogeneity: Impact to Brain Aging and Disease , 2019, Front. Aging Neurosci..

[68]  J. Westermarck,et al.  CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits , 2019, Neurobiology of Aging.

[69]  Denis Gris,et al.  Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release , 2019, Cells.

[70]  I. Ferrer,et al.  Aging‐related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes , 2018, Brain pathology.

[71]  F. Gomes,et al.  Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword , 2018, Molecular Neurobiology.

[72]  S. Ousman,et al.  Astrocytes and Aging , 2018, Front. Aging Neurosci..

[73]  S. Oliet,et al.  Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease , 2018, Acta neuropathologica communications.

[74]  N. Musi,et al.  Tau protein aggregation is associated with cellular senescence in the brain , 2018, Aging cell.

[75]  L. Barbeito,et al.  Phenotypic heterogeneity of astrocytes in motor neuron disease , 2018, Clinical & experimental neuroimmunology.

[76]  Juan Zhang,et al.  The Age-dependent Elevation of miR-335-3p Leads to Reduced Cholesterol and Impaired Memory in Brain , 2018, Neuroscience.

[77]  D. Souza,et al.  Leptin stimulates the release of pro-inflammatory cytokines in hypothalamic astrocyte cultures from adult and aged rats , 2018, Metabolic Brain Disease.

[78]  D. Baker,et al.  Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline , 2018, Nature.

[79]  Zhandong Liu,et al.  TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading , 2018, The Journal of experimental medicine.

[80]  Christopher M. Norris,et al.  Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases , 2018, Front. Aging Neurosci..

[81]  A. Serrano‐Pozo,et al.  Deciphering the Astrocyte Reaction in Alzheimer’s Disease , 2018, Front. Aging Neurosci..

[82]  Ronald C Petersen,et al.  Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. , 2018, The Journal of clinical investigation.

[83]  A. Puca,et al.  Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain , 2018, Journal of leukocyte biology.

[84]  Chulhee Choi,et al.  Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype. , 2018, Chemico-biological interactions.

[85]  Ben A. Barres,et al.  Normal aging induces A1-like astrocyte reactivity , 2018, Proceedings of the National Academy of Sciences.

[86]  J. Richardson,et al.  Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[87]  Galina A. Erikson,et al.  The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain , 2018, Cell reports.

[88]  K. Yamanaka,et al.  The multi-dimensional roles of astrocytes in ALS , 2018, Neuroscience Research.

[89]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[90]  S. Berger,et al.  Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence , 2016, Front. Aging Neurosci..

[91]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[92]  M. Sofroniew,et al.  Astrocyte roles in traumatic brain injury , 2016, Experimental Neurology.

[93]  L. Stanton,et al.  The Neurogenic Potential of Astrocytes Is Regulated by Inflammatory Signals , 2015, Molecular Neurobiology.

[94]  R. de Cabo,et al.  In vitro caloric restriction induces protective genes and functional rejuvenation in senescent SAMP8 astrocytes , 2015, Aging cell.

[95]  J. Meldolesi,et al.  Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.

[96]  A. Volterra,et al.  A neuron–glia signalling network in the active brain , 2001, Current Opinion in Neurobiology.

[97]  A. Araque,et al.  Tripartite synapses: glia, the unacknowledged partner , 1999, Trends in Neurosciences.